MPO and COVID-19: Potential mechanisms for dapsone’s efficacy in COVID-19 include decreasing inflammation via the inhibition of myeloperoxidase [211], inhibiting neutrophil tissue destruction, and acting as an NLPP3 inflammasome inhibitor [212].